₹ 1155.8
Key Takeaways
Risk factor
Strong & resilient to price shocks
Profitability factor
Very strong margins and returns
About
Max Healthcare Institute Limited provides healthcare services in India. It offers services in various specialties, including cancer care/oncology, cardiac sciences, neuro sciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery, minimal access/laparoscopic surgery, urology, gastroenterology, and aesthetic and reconstructive surgery. The company also provides Max@Home, a platform that...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.
Target Price
The average target price of MAXHEALTH.NS is 1254 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommen
